Skip to main content

Growing Demand of Medical Displays in Medical Industry | Business is Expected to Reach $2.33 Billion by 2023


Growing adoption of hybrid ORs, short replacement cycle of medical displays, increasing preference for minimally invasive treatments, and rising number of Diagnostic Imaging centers are the major factors driving the growth of medical display market. However, market saturation and the increased adoption of refurbished medical displays are expected to restrain the growth of this market to a certain extent.

Medical Display Market: Impact Analysis

1. Medical Display Industry, By Application & Region
2. Medical Display Industry, Developing Countries vs Developed Countries
3. Growing Adoption of Hybrid Operating Rooms
4. Short Replacement Cycles of Medical Displays
5. Development of Healthcare Infrastructure in Emerging Markets

The
medical display market was valued at USD 1.78 Billion in 2017 and is expected to reach USD 2.33 Billion by 2023, at a CAGR of 4.6%.

Key Questions Addressed in The Report:

1.
Who are the top 10 players operating in the global Medical Display market?
2. What are the drivers, restraints, opportunities, and challenges in the Medical Display Industry?
3. What are the
opportunities for stakeholders and provide details of the competitive landscape for key players?
4. What will be growth of Medical Display in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa?

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74058413

Medical Display Technology:

On the basis of technology, the LED-backlit LCD display segment accounted for the largest share of the global market in 2017. Long lifespan, better return on investment compared to CCFL, high-quality medical images, and the power efficiency offered by LED-backlit LCD are the major factors driving its adoption in the market.

Medical Display Color:

The color displays segment accounted for the largest share of the medical display market in 2017. Features such as high-quality images and multi-modality capability are driving the adoption of the color displays segment.

Applications of Medical Display:

The global market by application is segmented into diagnostic, surgical/interventional, dentistry, and other applications (clinical review, education, and conference and training). In 2017, the diagnostic application accounted for the largest share of the market.

North America and Europe to Dominate The Industry:

Geographically, the global market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2017, North America accounted for the largest share of the medical display market, followed by Europe. North America’s large share in the global market is attributed to factors such as high adoption of advanced technologies such as OLED and hybrid operating rooms, increasing healthcare expenditure, favorable reimbursement policies, and increasing volume of diagnostic tests and surgeries.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=74058413

Key Players:

Prominent players in the healthcare market are Barco (Belgium), EIZO (Japan), Sony (Japan), LG Display (South Korea), Novanta US), FSN Medical (South Korea), Advantech (Taiwan), Quest International (US), STERIS (UK), Jusha Medical (China), Double Black Imaging (US), Dell (US), HP (US), Shenzhen Beacon Display (China), COJE Display (South Korea), and Axiomtek (Taiwan).

Comments

Popular posts from this blog

NGS-Based RNA-Sequencing Industry is Growing at a CAGR of 20%

NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. NGS-based RNA-sequencing Market: Impact Analysis 1. NGS-Based RNA-Sequencing: Market Overview 2. Geographical Snapshot of the NGS-Based RNA-Sequencing Market 3. Rapid Growth in Precision Medicine 4. Growing Number of Research Activities Involving RNA-Seq 5. Increasing Applications of RNA-Seq in Research ( Cancer and Agricultural) The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global NGS-based RNA-sequencing market? 2. What are the drivers, restraints, opportunities, and challenges in the NGS-based RNA-sequencing Industry? 3. What are th...

Digital Diabetes Management Market to Reach $19.98 billion by 2024 | Market and Regional Growth Analysis

  Digital diabetes management solutions are smartphone-connected diabetes management devices and software platforms used by patients suffering from Type 1, Type 2, and gestational diabetes. Medical professionals also use these solutions to manage diabetes. Various digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery. Diabetes management applications, data management software & platforms, and services are used by patients and healthcare providers for remote monitoring, data analysis, and disease management. The Digital Diabetes Management Market is experiencing significant growth due to rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly...

Epigenetics Market | Major Market Dynamics Impacting The Global Industry

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strateg...